Wealth Enhancement Trust Services’s INmune Bio INMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-42
Closed -$68 – 1126
2026
Q2
$68 Buy
+42
New +$58 ﹤0.01% 1439

Other funds holding INMB

Wealth Enhancement Trust Services's INMB Position: Q3 2026 in Review

Wealth Enhancement Trust Services sold out of INmune Bio (INMB) in Q3 2026, closing a stake of 42 shares — an estimated $68 sold.

Wealth Enhancement Trust Services first reported a position in INMB in Q2 2026 and held it in 1 quarter. The position peaked at $68 in Q2 2026. 63 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Wealth Enhancement Trust Services reported no remaining INmune Bio position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Trust Services sold 42 INmune Bio shares in Q3 2026, an estimated $68.
  • Wealth Enhancement Trust Services first reported a position in INmune Bio in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Trust Services's INmune Bio position peaked at $68 in Q2 2026.
  • 63 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q3 2026, filed 7 Oct 2026.